VOYA Investment Management’s Lyell Immunopharma LYEL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-50,329
| Closed | -$27.1K | – | 2707 |
|
2025
Q1 | $27.1K | Sell |
50,329
-2,606
| -5% | -$1.4K | ﹤0.01% | 2604 |
|
2024
Q4 | $33.9K | Sell |
52,935
-2,604
| -5% | -$1.67K | ﹤0.01% | 2717 |
|
2024
Q3 | $76.6K | Sell |
55,539
-3,046
| -5% | -$4.2K | ﹤0.01% | 2712 |
|
2024
Q2 | $84.9K | Hold |
58,585
| – | – | ﹤0.01% | 2705 |
|
2024
Q1 | $131K | Sell |
58,585
-14,623
| -20% | -$32.6K | ﹤0.01% | 2571 |
|
2023
Q4 | $142K | Hold |
73,208
| – | – | ﹤0.01% | 2673 |
|
2023
Q3 | $108K | Buy |
73,208
+2,768
| +4% | +$4.07K | ﹤0.01% | 2707 |
|
2023
Q2 | $224K | Buy |
70,440
+2,999
| +4% | +$9.54K | ﹤0.01% | 2531 |
|
2023
Q1 | $159K | Hold |
67,441
| – | – | ﹤0.01% | 2603 |
|
2022
Q4 | $234K | Hold |
67,441
| – | – | ﹤0.01% | 2487 |
|
2022
Q3 | $494K | Buy |
67,441
+1,820
| +3% | +$13.3K | ﹤0.01% | 2032 |
|
2022
Q2 | $428K | Buy |
+65,621
| New | +$428K | ﹤0.01% | 1932 |
|